ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2022

The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors.

Meiyuan Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.